Featured Research

from universities, journals, and other organizations

Mutated Clotting Gene Raises Risk Of Heart Disease In Blacks, Not Whites

Date:
April 24, 2001
Source:
American Heart Association
Summary:
A gene involved in blood clotting is linked to a six-fold increase in risk for heart disease in African-Americans, according to the first prospective study to examine the gene as it relates to heart disease published in the March 13th issue of Circulation: Journal of the American Heart Association.

Dallas, April 23 – A gene involved in blood clotting is linked to a six-fold increase in risk for heart disease in African-Americans, according to the first prospective study to examine the gene as it relates to heart disease published in the March 13th issue of Circulation: Journal of the American Heart Association.

"Our findings underscore the importance of studying genetic risk factors by ethnic group," says Kenneth K. Wu, M.D., Ph.D., lead author of the study and professor and director of the Hematology and Vascular Biology Research Center at the University of Texas, Houston Health Science Center. "They also provide a genetic basis for differential risk factors of heart attacks between African-Americans and whites." The gene in the study is the blueprint for a protein called thrombomodulin, which is found in the lining of the blood vessel walls. The protein converts the enzyme thrombin from a clotting agent into an anti-clotting agent. A common variance in the thrombomodulin gene occurs when alanine (an amino acid) is replaced by valine at amino acid position 455. This shift in gene structure has been previously associated with heart attack risk.

Genes give instructions on how amino acids link together to form proteins. Any shift in the order in which amino acids are linked can cause the protein to function abnormally. Reduced levels of normal thrombomodulin as a result of the altered gene may cause an increased tendency for blood vessel damage and blood clots.

"We have identified a genetic marker for predicting increased heart attack risk in African-Americans. Our results show that a single amino acid change in the thrombomodulin gene is an independent risk factor for coronary heart disease in blacks," says Wu.

The same small shift in the structure of the thrombomodulin gene was not associated with coronary heart disease (CHD) risk in white individuals.

Researchers recently analyzed the association of this structure with CHD in a prospective follow-up of the Atherosclerosis Risk in Communities (ARIC) study. ARIC is a population-based study that recruited 15,792 men and women ages 45-64 from four different communities in the United States. Baseline examinations, including blood pressures and samples of blood and DNA, were conducted between 1987 and 1989. Participants were reexamined on a three-year cycle.

Researchers identified 467 individuals who developed CHD during an average of five years of follow-up. Thrombomodulin genotypes at the 455 position were determined in 376 of these cases (23 percent black, 77 percent white), as well as a reference sample of 461 study participants. There are two copies of the thrombomodulin gene (one from each parent). Therefore genotypes are given as a two-letter "code." For example, a person with two copies of the unaltered form of the gene will have an AA genotype (alanine-alanine). Those with one regular form of the gene and one altered form will have an AV genotype (alanine-valine), those with two altered forms of the gene will be VV (valine-valine). Researchers combined the VV and AV results in their analysis.

African-Americans with at least one copy of the altered form of thrombomodulin (AV or VV) had a 6.1 times greater risk for CHD after adjustment for other CHD risk factors. In contrast, the AV or VV genotype was not significantly associated with CHD risk in whites.

The AA genotype was more common in those without CHD. Ninety-eight out of 105 (93 percent) of healthy blacks and 237 out of 356 (67 percent) of healthy whites had the AA genotype.

Why the thrombomodulin-455 structure is associated with higher risk of CHD in blacks than whites is not clear. Wu says one possible explanation is that the gene may act differently in blacks than whites. "It is likely that the valine structure is a risk factor for heart attacks in all blacks in the United States, since ARIC is a population-based study. However, I would like to caution that the number of African-Americans with CHD in our study group is relatively small when compared to the number of white cases," says Wu. The group is analyzing a large number of cases to substantiate the results of this study.

The research team plans to study the association of heart attacks and stroke with other genes that affect clotting.

Co-authors include Nena Aleksic, Ph.D.; Chul Ahn, Ph.D.; Eric Boerwinkle, Ph.D.; Aaron R. Folsom, M.D.; and Harinder Juneja, M.D.

This study was supported by the National Heart, Lung and Blood Institute, NIH.


Story Source:

The above story is based on materials provided by American Heart Association. Note: Materials may be edited for content and length.


Cite This Page:

American Heart Association. "Mutated Clotting Gene Raises Risk Of Heart Disease In Blacks, Not Whites." ScienceDaily. ScienceDaily, 24 April 2001. <www.sciencedaily.com/releases/2001/04/010424072534.htm>.
American Heart Association. (2001, April 24). Mutated Clotting Gene Raises Risk Of Heart Disease In Blacks, Not Whites. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2001/04/010424072534.htm
American Heart Association. "Mutated Clotting Gene Raises Risk Of Heart Disease In Blacks, Not Whites." ScienceDaily. www.sciencedaily.com/releases/2001/04/010424072534.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins